• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. 1.5T LINX, 15B; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. 1.5T LINX, 15B; ANTI-REFLUX IMPLANT Back to Search Results
Model Number LXMC15
Device Problems Device Appears to Trigger Rejection (1524); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Dysphagia/ Odynophagia (1815); Vomiting (2144)
Event Date 11/02/2021
Event Type  Injury  
Event Description
It was reported via clinical trial patient experience vomiting.
 
Manufacturer Narrative
(b)(4).Lot number was received and dhr is pending review.When the review is completed, a supplemental medwatch will be sent with a summary of the evaluation.Additional information received: panhandle surgical group.Sex: female.Age (at time of consent): (b)(6).Model: lxmc15.Device lot number: 28530.Date of surgery: (b)(6) 2021.Adverse event term: vomiting.Severity: severe.Is the adverse event serious? yes.Required in-patient hospitalization or prolongation of existing hospitalization: yes.Admission date: (b)(6) 2021.Discharge date from hospital: (b)(6) 2021.Intervention/treatment: diagnostic intervention: yes.Diagnostic imaging: yes.Drug therapy: yes.
 
Manufacturer Narrative
(b)(4).Date sent: 1/11/2021.Investigation summary: an analysis of the product could not be performed since a physical sample was not received for evaluation.As part of ethicon's quality process, all devices are manufactured, inspected, and distributed to approved specifications.If the product is received at a later date, the investigation will be updated as applicable.An evaluation of the manufacturing documentation could not be completed as the lot number was not provided.Additional information received: 28530 is not a valid lot number.
 
Manufacturer Narrative
(b)(4).Date sent: 3/8/2022.Investigation summary: overall review of the device function and dimensions show no anomalies from a device that has been reasonably changed as part of the explant procedure.Visual analysis was consistent with an explanted device, and link length and tensile force were found to meet the applicable specifications.No further investigation will be conducted on this complaint as the device is found to meet the specifications.Overall, no analysis conclusions relevant to the patient experience were found.A manufacturing record evaluation was performed for the finished device batch number: 25221, and no non-conformances were identified.Additional information received: patient developed of a left sided empyema requiring thoracotomy with decortication.Required in-patient hospitalization or prolongation of existing hospitalization: yes.Admission date: on (b)(6) 2022.Discharge date: on (b)(6) 2022.Relationship to study device: causal relationship.Relationship to primary study procedure: causal relationship.Dilation performed: yes.Indicate type of dilation? pneumatic.Date of dilation: on (b)(6) 2021.Diagnostic intervention: yes.Diagnostic imaging: yes.Drug therapy: yes.Linx explant: yes.According to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated: yes.
 
Manufacturer Narrative
(b)(4).Date sent: 2/24/2022.Additional information received: device lot number: 25221.Dysphagia / moderate.Pneumatic dilation was performed on (b)(6) 2021.Relationship to study device: casual relationship.Relationship to study procedure: casual relationship.Diagnostic imaging was done.Drug therapy was provided.(prescription based).Outcome: recovering/resolving.Did this event result in the subject's discontinuation of the study? yes.Linx explant was done.Was the linx explant a result of an adverse event per protocol definitions?: yes.If yes, choose the primary ae log line, start date and term: #002 on (b)(6) 2021-dysphagia participant had anxiety about implant: no.Medical need for high field strength mri or other testing: no.Participant wishes to have alternative gerd treatment requiring linx explant: no.Continued gerd symptom: no.Laparoscopic: yes.The date of the explant was on (b)(6) 2022.Lot number was received and dhr is pending review.When the review is completed, a supplemental medwatch will be sent with a summary of the evaluation.
 
Manufacturer Narrative
(b)(4); date sent: 10/28/2022.Additional information received: end date : blank - (b)(6) 2022.Outcome : recovering/resolving: recovered/resolved.
 
Manufacturer Narrative
(b)(4).Date sent: 8/21/2023.Additional information received: awareness date : 01 dec 2021 - 16 nov 2021.Awareness date : 16 nov 2021 - 01 dec 2021.Based on the audit trail for this implant.The lot# was corrected to 28536 on 18jan2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
1.5T LINX, 15B
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4545 creek road
cincinnati OH
Manufacturer Contact
kara ditty-bovard
4188 lexington avenue north
shoreview 55126
6107428552
MDR Report Key12952407
MDR Text Key282780669
Report Number3008766073-2021-00239
Device Sequence Number1
Product Code LEI
UDI-Device Identifier00855106005356
UDI-Public00855106005356
Combination Product (y/n)N
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 08/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberLXMC15
Device Catalogue NumberLXMC15
Device Lot Number28536
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/04/2022
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 11/16/2021
Initial Date FDA Received12/07/2021
Supplement Dates Manufacturer Received01/11/2022
02/09/2022
02/25/2022
10/27/2022
08/10/2023
Supplement Dates FDA Received01/11/2022
02/24/2022
03/08/2022
10/28/2022
08/21/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/09/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age42 YR
Patient SexFemale
Patient Weight82 KG
-
-